血浆循环miR-328-3p与风湿性心脏病合并心房颤动的关系

Abstract
Figure/Table
References (20)
Related Citation (15)

Download: PDF (0 KB) HTML (39 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate whether plasma circulating microRNA-328-3p is related to the occurrence of rheumatic heart disease with atrial fibrillation,and to explore its pathogenesis.Methods A total of 19 patients with rheumatic heart disease and atrial fibrillation from August 2017 to July 2018 were selected as observation group and 21 patients with sinus rhythm of rheumatic heart disease were selected as control group.The expression of plasma circulating microRNA-328-3p was detected by qRT-PCR.The ROC curve of the relative expression of plasma circulating microRNA-328-3p was analyzed.Bioinformatics software such as mirFocus and starBase were used to predict the bioinformatics of microRNA-328-3p.Results The expression level of plasma circulating microRNA-328-3p of the observation group was 0.31±0.05,lower than 0.69±0.03 in the control group,the difference was statistically significant(P<0.01).ROC curve analysis showed that the area under the plasma circulating miR-328-3p curve was 0.9323,95%confidence interval was 0.8598-1.0005 (P<0.01).Bioinformatics predictions showed that the KEGG signaling pathways of microRNA-328-3p were mainly related to cell division,binding protein,ventricular formation,insulin receptor signaling pathway,PI3K pathway,Wnt pathway and so on.The target genes are TLE1,STT3A,USP37,EN2,NRIP1,FOXO4 and so on.Conclusion Plasma circulating microRNA-328-3p may be involved in the occurrence of rheumatic heart disease with atrial fibrillation,and can be used as a biomarker of rheumatic heart disease with atrial fibrillation.It may lead to the occurrence of rheumatic heart disease with atrial fibrillation by regulating PI3K pathway and Wnt pathway.

Key words： MiR-328-3p Rheumatic heart disease Atrial fibrillation Biomarkers Signaling pathways

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	TANG Chun-shi
	LU Xin-lin
	TAN Li-hui
	CHEN Wen-jiang

Cite this article:

TANG Chun-shi,LU Xin-lin,TAN Li-hui, et al. Relationship between plasma circulating microRNA-328-3p and rheumatic heart disease with atrial fibrillation[J]. 中国当代医药, 2019, 26(16): 8-11转15.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2019/V26/I16/8

[1]	陈伟伟，高润霖，刘力生，等.《中国心血管病报告 2017》概要[J].中国循环杂志，2018，33（1）：1-8.
[2]	Macle L，Cairns J，Leblanc K，et al.2016 focused update of the canadian cardiovascular society guidelines for the management of atrial fibrillation[J].Can J Cardiol，2016，32（10）：1170-1185.
[4]	Fu S，Huang L，Wang Y，et al.MicroRNA as a novel player in atrial fibrillation[J].Front Genet，2014，30（5）：97.
[12]	刘磊，于宗良，邓红平.miR-328在心血管疾病和肿瘤中的应用[J].医学综述，2018，24（3）：476-480.
[13]	陈文江，陈灿.微RNA与心房颤动发病机制的研究进展[J].医学综述，2015，21（5）：801-803.
[3]	Tao H，Shi KH，Yang JJ，et al.Epigenetic mechanisms in atrial fibrillation：new insights and future directions[J].Trends Cardiovasc Med，2016，26（4）：306-318.
[5]	Luo X，Yang B，Nattel S.MicroRNAs and atrial fibrillation：mechanisms and translational potential[J].Nat Rev Cardiol，2015，12（2）：80-90.
[6]	Lu Y，Zhang Y，Wang N，et al.MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation[J].Circulation，2010，122（23）：2378-2387.
[7]	Zhou Q，Maleck C，von Ungern-Sternberg SNI，et al.Circulating microRNA-21 correlates with left atrial low-voltage areas and is associated with procedure outcome in patients undergoing atrial fibrillation ablation[J].Circ Arrhythm Electrophysiol，2018，11（6）：e006242.
[8]	Wang J，Liew O，Richards A，et al.Overview of microRNAs in cardiac hypertrophy，fibrosis，and apoptosis[J].Int J Mol Sci，2016，17（5）：749.
[9]	Wang Y，Kang W，Wang X，et al.Functional role and mechanism of microRNA-28b in atrial myocyte in a persistent atrial fibrillation rat model[J].Med Sci Monit，2016，22（30）：3073-3078.
[10]	Li JH，Liu S，Zhou H，et al.starBase v2.0：decoding miRNA-ceRNA，miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data[J].Nucleic Acids Res，2014，42：D92-97.
[11]	Li JH，Liu S，Zheng LL，et al.Discovery of protein-lncRNA interactions by integrating large-scale CLIP-Seq and RNASeq datasets[J].Front Bioeng Biotechnol，2014，14（2）：88.
[14]	刘长召，王玲，陈文江，等.微小RNA与心脏电重构的研究进展[J].中国医学创新，2015，12（18）：154-156.
[15]	Zhao D，Li C，Yan H，et al.Cardiomyocyte derived miR-328 promotes cardiac fibrosis by paracrinely regulating adjacent fibroblasts[J].Cell Physiol Biochem，2018，46（4）：1555-1565.
[16]	冯荣，傅广，黄树斌，等.miR-328、miR-147 和 miR-22 在冠心病患者中的表达变化及临床意义[J].中国动脉硬化杂志，2015，23（8）：812-816.
[17]	王玺，邱春光，黄振文，等.血浆miR-328在心房颤动中的表达水平及其临床意义[J].中华心血管病杂志，2013，41（2）：126-129.
[18]	Soeki T，Matsuura T，Tobiume T，et al.Clinical，electrocardiographic，and echocar diographicpara meterco mbination predicts the onset of atrial fibrillation[J].Circ J，2018，82（9）：2253-2258.
[19]	Soeki T，Matsuura T，Bando S，et al.Relationship between localproduction of microRNA-328and atrialsub stratere modeling in atrial fibrillation[J].J Cardiol，2016，68（6）：472-477.
[20]	McManus DD，Lin H，Tanriverdi K，et al.Relations between circulating microRNAs and atrial fibrillation：data from the Framingham Offspring Study[J].Heart Rhythm，2014，11（4）：663-669.